These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8890402)

  • 1. Inhibitors of stone formation.
    Worcester EM
    Semin Nephrol; 1996 Sep; 16(5):474-86. PubMed ID: 8890402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary calcium oxalate crystal growth inhibitors.
    Worcester EM
    J Am Soc Nephrol; 1994 Nov; 5(5 Suppl 1):S46-53. PubMed ID: 7873744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Uronic-acid-rich protein: a new glycoprotein inhibiting the crystallization of calcium oxalate in vitro].
    Atmani F; Lacour B; Daudon M
    Nephrologie; 1996; 17(3):157-62. PubMed ID: 9064564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoprotein calcium oxalate crystal growth inhibitor in urine.
    Worcester EM; Nakagawa Y; Coe FL
    Miner Electrolyte Metab; 1987; 13(4):267-72. PubMed ID: 3306319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glycoprotein inhibitors of urinary calculi formation].
    Berland Y; Dussol B
    Nephrologie; 1993; 14(4):183-7. PubMed ID: 8232713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of nephrocalcin in inhibition of calcium oxalate crystallization and nephrolithiasis.
    Coe FL; Nakagawa Y; Asplin J; Parks JH
    Miner Electrolyte Metab; 1994; 20(6):378-84. PubMed ID: 7783700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uropontin in urinary calcium stone formation.
    Hoyer JR
    Miner Electrolyte Metab; 1994; 20(6):385-92. PubMed ID: 7783701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inter-alpha-inhibitor: a protein family involved in the inhibition of calcium oxalate crystallization.
    Atmani F; Mizon J; Khan SR
    Scanning Microsc; 1996; 10(2):425-33; discussion 433-4. PubMed ID: 9813621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis.
    Tsujihata M; Miyake O; Yoshimura K; Kakimoto KI; Takahara S; Okuyama A
    J Urol; 2000 Nov; 164(5):1718-23. PubMed ID: 11025758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulators of urinary stone formation.
    Khan SR; Kok DJ
    Front Biosci; 2004 May; 9():1450-82. PubMed ID: 14977559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole urinary proteins coat calcium oxalate monohydrate crystals to greatly decrease their adhesion to renal cells.
    Kumar V; Farell G; Lieske JC
    J Urol; 2003 Jul; 170(1):221-5. PubMed ID: 12796693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of urinary bikunin in the inhibition of calcium oxalate crystallization.
    Atmani F; Khan SR
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S385-8. PubMed ID: 10541269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitaxial deposition of calcium oxalate on uric acid rich stone matrix is induced by a 29 kDa protein.
    Srinivasan S; Kalaiselvi P; Varalakshmi P
    Clin Chim Acta; 2006 Feb; 364(1-2):267-74. PubMed ID: 16139257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of uropontin in calcium oxalate lithogenesis].
    Paulhac P; Desgrandchamps F; Dumas JP; Teillac P; Le Duc A; Colombeau P
    Prog Urol; 2002 Feb; 12(1):114-7. PubMed ID: 11980003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of urinary organic macromolecules on crystallization of calcium oxalate: enhancement of nucleation.
    Drach GW; Thorson S; Randolph A
    Trans Am Assoc Genitourin Surg; 1979; 71():62-6. PubMed ID: 161827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Tamm-Horsfall glycoprotein and Nephrocalcin in calcium oxalate monohydrate crystallization processes.
    Hess B
    Scanning Microsc; 1991 Sep; 5(3):689-95; discussion 696. PubMed ID: 1808706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
    Ryall RL; Chauvet MC; Grover PK
    BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New pathophysiologic aspects of nephrolithiasis].
    Hess B
    Schweiz Med Wochenschr; 1989 Jul; 119(26):929-34. PubMed ID: 2678432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleation, adhesion, and internalization of calcium-containing urinary crystals by renal cells.
    Lieske JC; Deganello S
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S422-9. PubMed ID: 10541277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Future perspective on the prevention of nephrolithiasis].
    Kohjimoto Y; Shinka T; Morimoto S; Nishihata M
    Hinyokika Kiyo; 2004 Aug; 50(8):591-6. PubMed ID: 15471083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.